Mats Wahlstrom 13D and 13G filings for TriSalus Life Sciences, Inc.:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Shares have been adjusted for stock splits.
| Reported DateTime | Transaction Date | Type | Company Symbol | Filed By Symbol | Shares Owned % Owned | Shares Vs. Prev Report | View |
| 2025-08-01 5:16 pm Purchase | 2025-07-31 | 13D | TriSalus Life Sciences, Inc. TLSI | Mats Wahlstrom | 2,987,881 6.000% | 190,444 (+6.81%) | Filing |
| 2024-12-19 4:12 pm Purchase | 2024-12-17 | 13D | TriSalus Life Sciences, Inc. TLSI | Mats Wahlstrom | 2,797,437 9.000% | 52,895 (+1.93%) | Filing |
| 2023-08-21 4:36 pm Purchase | 2023-08-10 | 13D | TriSalus Life Sciences, Inc. TLSI | Mats Wahlstrom | 2,744,542 10.400% | 2,744,542 (New Position) | Filing |